- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-08-0019006

About Aci Pharma Private Limited
Data last updated:
Aci Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 March 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC119266. Its GSTIN is 07AAECA1713F1Z8 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kartik Sahay and Bharti Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Upper Ground Floor Plot No 23 Khasra No – 17/12/21/1, Pochanpur Extn A Block Gali No 2 New Village Pochanpur, New Delhi, Delhi, India – 110077.
As per the financials filed for FY 2024, the company reported a revenue of ₹64,244, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹1.34 Lakh (net margin -208.9%) and EBITDA of -₹1.1 Lakh (EBITDA margin -171.4%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years and 56% over five years.
Aci Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-08-0019006). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acipharm.com.
Company details
Recognitions & Rankings of Aci Pharma
Contact details
Aci Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is acipharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUpper Ground Floor Plot No 23 Khasra No – 17/12/21/1, Pochanpur Extn A Block Gali No 2 New Village Pochanpur, New Delhi, Delhi, India – 110077
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare, API Manufacturers
To see the full contact details of Aci Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aci Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aci Pharma Private Limited, buy the company report.
Financials of Aci Pharma Private Limited
FY 2025 filings availableAci Pharma Private Limited reported revenue of ₹64,244 (down 94% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 56% over five years, including a 94% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -171.4% | ||||
| Net Profit Margin | -208.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aci Pharma Private Limited, buy the company report.
Board of directors of Aci Pharma Private Limited
Aci Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kartik Sahay | Director | 22 Nov 2004 | 21 Years 11 Months | Current |
| Bharti Sahay | Director | 01 Apr 2008 | 18 Years 7 Months | Current |
| Priti Chetan | Additional Director | 17 Sep 2021 | 5 Years 2 Months | Current |
Auditor
Aci Pharma Private Limited is audited by K K BARANWAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K K BARANWAL & ASSOCIATES | FY 2023 | 024207N |
Shareholding
The shareholding of Aci Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aci Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aci Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aci Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aci Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECA1713F1Z8 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aci Pharma Private Limited, buy the company report.
Recent activity
Aci Pharma Private Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Priti Chetan was appointed as Additional Director on 17 Sep 2021.
Frequently asked questions
Aci Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 March 2003 (23+ years old) and is registered under CIN U24239DL2003PTC119266.
Aci Pharma has 3 current directors:
- Kartik Sahay - Director
- Bharti Sahay - Director
- Priti Chetan - Additional Director
The latest financial statements of Aci Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aci Pharma is 07AAECA1713F1Z8, registered in Delhi.
The CIN (Corporate Identification Number) of Aci Pharma is U24239DL2003PTC119266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aci Pharma was incorporated on 05 March 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Priti Chetan was appointed as Additional Director on 17 Sep 2021. Gouri Shanker Sahay ceased to be Director on 26 Sep 2020. Sweta Bora ceased to be Director on 26 Sep 2020. Aci Pharma has 7 board changes on record in total.
Yes, Aci Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-08-0019006).
Aci Pharma can be reached through the website acipharm.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Aci Pharma is at Upper Ground Floor Plot No 23 Khasra No – 1712211, Pochanpur Extn A Block Gali No 2 New Village Pochanpur, New Delhi, Delhi, India – 110077.

